Ad
INDP Stock Quote Trading Chart Indaptus Therapeutics Inc.
home / stock / indp / indp quote
Quote | Indaptus Therapeutics Inc. (NASDAQ:INDP)
| Last: | $2.755 |
|---|---|
| Change Percent: | 2.55% |
| Open: | $2.68 |
| Close: | $2.755 |
| High: | $2.8 |
| Low: | $2.68 |
| Volume: | 5,727 |
| Last Trade Date Time: | 09/29/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
INDP Last Five Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $2.755 | $2.68 | $2.755 | $2.8 | $2.68 | 5,727 | 09-29-2023 |
| $2.75 | $2.86 | $2.75 | $2.86 | $2.74 | 11,573 | 09-28-2023 |
| $2.66 | $2.76 | $2.66 | $2.802 | $2.65 | 5,185 | 09-27-2023 |
| $2.78 | $2.52 | $2.78 | $2.8458 | $2.52 | 24,654 | 09-26-2023 |
| $2.49 | $2.76 | $2.49 | $2.85 | $2.4 | 30,414 | 09-25-2023 |
| $2.71 | $3.21 | $2.71 | $3.3 | $2.7 | 44,098 | 09-22-2023 |
| $3.33 | $3.44 | $3.33 | $3.44 | $3.22 | 20,337 | 09-21-2023 |
| $3.5 | $3.97 | $3.5 | $4 | $3.43 | 36,476 | 09-20-2023 |
| $3.95 | $3.77 | $3.95 | $4.08 | $3.7053 | 80,695 | 09-19-2023 |
| $3.68 | $3.33 | $3.68 | $3.7499 | $3.31 | 49,330 | 09-18-2023 |
| $3.38 | $3.15 | $3.38 | $3.3999 | $3.118 | 37,117 | 09-15-2023 |
| $3.15 | $3.19 | $3.15 | $3.19 | $3.08 | 12,899 | 09-14-2023 |
| $3.14 | $3.17 | $3.14 | $3.17 | $3.0001 | 10,390 | 09-13-2023 |
| $3.06 | $3.08 | $3.06 | $3.12 | $2.98 | 4,700 | 09-12-2023 |
| $3.07 | $3.13 | $3.07 | $3.17 | $3.07 | 7,620 | 09-11-2023 |
| $3.06 | $3.18 | $3.06 | $3.19 | $3.06 | 11,517 | 09-08-2023 |
| $3.16 | $3.17 | $3.16 | $3.1799 | $3.0108 | 10,538 | 09-07-2023 |
| $3.02 | $3.13 | $3.02 | $3.13 | $3.02 | 6,061 | 09-06-2023 |
| $3.04 | $3 | $3.04 | $3.12 | $2.925 | 10,789 | 09-05-2023 |
| $2.94 | $2.95 | $2.94 | $3.05 | $2.912 | 11,989 | 09-04-2023 |
Stock Information
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
Ad
-
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced today that Jeffrey A. Meckler, Chief Executive ...
-
NEW YORK, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the LD Micro Main Event XVI. The conference is being held on October 3 – 5, 2023 at the Luxe Sunset...
-
NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP) announces that Indaptus' CEO, Jeffrey Meckler will p...